)
Edge31 Oct 2025
Rolls-Royce: Full Thrust Ahead
From century-old crafted perfection to pandemic shock and reset, Rolls-Royce's story is shaped by heritage, turbulence, and a disciplined climb back.
Recursion Pharmaceuticals (RXRX) investor relations material
Recursion Pharmaceuticals Morgan Stanley 23rd Annual Global Healthcare Conference summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Morgan Stanley 23rd Annual Global Healthcare Conference summary8 Sep, 2025
Industry trends and competitive positioning
Focus on first-in-class or best-in-class therapies in undruggable biology, differentiating from competitors, including those in China.
AI-driven platform leverages multimodal data, generative AI, and active learning to address high failure rates in drug discovery.
Integration of wet lab automation and advanced dry lab computing, including a proprietary supercomputer, enables large-scale experimentation and model training.
Regulatory shifts, such as reduced reliance on animal models and use of surrogate endpoints, are seen as tailwinds for platform efficiency.
Anticipation of increasing industry pressure for efficiency and better medicines, with investments aimed at reducing time and cost to market.
Platform evolution and technology integration
Merger with Exscientia has unified biology and chemistry-centric approaches, enhancing internal and partner programs.
VOLT2 model integrated early in discovery workflow, broadening hypothesis generation and improving triage speed and accuracy.
Open sourcing select models and datasets to commoditize tools and foster industry advancement, while retaining proprietary advantages.
Causal AI and multiomic data, including partnerships with Tempus and Helix, improve patient stratification and clinical trial design.
Proprietary and partner data integration enables forward and reverse genetics, expanding opportunities across therapeutic areas.
Pipeline highlights and clinical progress
CDK7 program (six seventeen) focuses on combination therapy, safety profile, and patient stratification; FAP program shows promising early data with significant polyp burden reduction.
MALT1 program targets B cell malignancies with improved safety profile for combination therapies, addressing unmet needs in specific patient populations.
RBM39 program leverages phenomics for target identification and rapid compound design, with early clinical data expected next year.
Platform enables rapid iteration and evidence accumulation, supporting efficient go/no-go decisions and portfolio prioritization.
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Recursion Pharmaceuticals earnings date
Q3 20255 Nov, 2025
Next Recursion Pharmaceuticals earnings date
Q3 20255 Nov, 2025
The essential earnings season companion
The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Recursion Pharmaceuticals Inc is a biotechnology company leveraging machine learning and automation to discover and develop new therapeutics. The company focuses on using its technology platform to identify treatments across a range of diseases, including rare and complex conditions. Recursion Pharmaceuticals operates within the healthcare and biotechnology sectors. The company is headquartered in Salt Lake City, Utah, and its shares are listed on the NASDAQ.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage